RijksoverheidGovernanceNetherlands Sets Sights on Global Biotech...The Netherlands has set itself an ambitious goal: to be among the global leaders in biotechnology by 2040. This vision is backed by an initial commitment of €1.3 billion in funding. more ➔
123rf.com/guniitaNeurodegenerative DisordersNLS and Kadimastem: Swiss-israeli merger i...NLS Pharmaceutics secures US$2m equity funding and signs US$25m equity facility to support merger with Kadimastem (Israel) to combine expertise in aiming to become a leader in regenerative medicine in … more ➔
wikicommonsUnited KingdomUK Government invests millions into new he...UK focuses on digital health research: 600 british pounds (US$764m) for new data platform according to the five recommendations of the Sudlow report. more ➔
TIRmed Pharma ABImmunmodulationSwedish TIRmed Pharma raises 4,3m€ again...TIRmed Pharma secures 4,3m€ to advance immunomodulatory treatment options for atopic dermatitis into clinical development. Stockholm-based TIRmed Pharma has closed this funding round, led by Sciety … more ➔
Menarini GroupPartnershipMenarini and ERBC collaborateFrench ERBC and Menarini Biotech from Italy forge a new strategic alliance to accelerate biopharmaceutical development. more ➔
Freepik.comSwitzerlandSwitzerland needs more efforts in biomedic...In February 2025, the Federal Office of Public Health (FOPH) announced that the Masterplan in Biomedicine will be discontinued. This sends a troubling signal at a time of growing protectionism and potential … more ➔
Johnson & JohnsonAntiinflammationMorphosys’ antibody still shining &#...The case of the psoriasis antiinflammation antibody guselkumab is a story of deals and cooperation and selling and buying royalties to fuel other innovation paths. J&J is right in the middle of the game … more ➔
American Academy of Dermatology;doi.org/10.1016/j.jaad.2019.03.056FinancingMoonLake in US$500m debt deal with Hercule...Swiss MoonLake Immunotherapeutics AG has secured up to US$500m in non-dilutive financing from life sciences debt specialist Hercules Capital to finance the potential 2027 launch of sonelokimab in hidradenitis … more ➔
Audiovisual Librairy of the European CommissionEU CommissionEU bioeconomy strategy enters crucial phas...Europe’s decision on how to combine economic growth and decarbonisation in the future depends on the renewal of the EU bioeconomy strategy. The question is whether the EU will fall further behind globally … more ➔
market.usRegulatoryEMA set to simplify biosimilar approvalThe EMA has asked the industry to share their thoughts on its draft guidelines for developing and assessing biosimilars. The idea is to make it easier for patients in the EU to get access to biosimilars, … more ➔
Rijksoverheid
123rf.com/guniita
wikicommons
TIRmed Pharma AB
Menarini Group
Freepik.com
Johnson & Johnson
American Academy of Dermatology;doi.org/10.1016/j.jaad.2019.03.056
Audiovisual Librairy of the European Commission
market.us